These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1002 related articles for article (PubMed ID: 18158087)
1. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis. Khanna R; Smith MJ Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087 [TBL] [Abstract][Full Text] [Related]
2. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Piecoro LT; Potoski M; Talbert JC; Doherty DE Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817 [TBL] [Abstract][Full Text] [Related]
3. Asthma-related healthcare services utilization by African-Americans enrolled in West Virginia Medicaid. Pawar V; Smith MJ Respir Med; 2006 Sep; 100(9):1579-87. PubMed ID: 16495039 [TBL] [Abstract][Full Text] [Related]
4. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population. Ollendorf DA; Peterson AN; Doyle J; Huse DM Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236 [TBL] [Abstract][Full Text] [Related]
5. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program. Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935 [TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [TBL] [Abstract][Full Text] [Related]
7. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors]. Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904 [TBL] [Abstract][Full Text] [Related]
8. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060 [TBL] [Abstract][Full Text] [Related]
10. Cost and utilization analysis of a pediatric emergency department diversion project. Wang C; Villar ME; Mulligan DA; Hansen T Pediatrics; 2005 Nov; 116(5):1075-9. PubMed ID: 16263992 [TBL] [Abstract][Full Text] [Related]
11. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus. Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392 [TBL] [Abstract][Full Text] [Related]
12. The cost of Medicaid-covered services provided to disabled adults with neurologic disorders: implications for managed care. Gardner EN; Murtaugh CM; Ray NF; Thamer M Am J Manag Care; 1999 Nov; 5(11):1417-25. PubMed ID: 10662415 [TBL] [Abstract][Full Text] [Related]
13. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310 [TBL] [Abstract][Full Text] [Related]
14. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700 [TBL] [Abstract][Full Text] [Related]
15. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme. Khanna R; Jariwala K; West-Strum D J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524 [TBL] [Abstract][Full Text] [Related]
16. Biologic disease-modifying drug treatment patterns and associated costs for patients with rheumatoid Arthritis. McBride S; Sarsour K; White LA; Nelson DR; Chawla AJ; Johnston JA J Rheumatol; 2011 Oct; 38(10):2141-9. PubMed ID: 21844154 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145 [TBL] [Abstract][Full Text] [Related]
18. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. Joyce AT; Smith P; Khandker R; Melin JM; Singh A J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658 [TBL] [Abstract][Full Text] [Related]
19. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734 [TBL] [Abstract][Full Text] [Related]
20. Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006. Tu HA; Bos JH; Woerdenbag HJ; Visser ST; Wilschut JC; van Assen S; de Jong-van den Berg LT; Postma MJ Clin Ther; 2010 Jan; 32(1):133-44. PubMed ID: 20171419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]